Literature DB >> 11100813

Cutaneous epithelioid malignant nerve sheath tumor with rhabdoid features: a histologic, immunohistochemical, and ultrastructural study of three cases.

M B Morgan1, L Stevens, J Patterson, M Tannenbaum.   

Abstract

INTRODUCTION: Malignant rhabdoid tumors are morphologically defined as sheets of loosely cohesive cells with eccentric nuclei and hyaline, paranuclear inclusions. Although originally described as a distinctive renal neoplasm of childhood, these tumors have since been described in all age groups and in a variety of extrarenal sites. In the latter setting, it is thought that the rhabdoid phenotype is comprised of histogenetically unrelated tumors, that regardless of histogenesis, pursue a biologically aggressive behavior.
METHODS: We report on the clinical, histologic, immunophenotypic, and ultrastructural characteristics of three cases of cutaneous malignant rhabdoid tumor.
RESULTS: Each of the cases arose on the trunk or the extremity of elderly men. None of the patients had neurofibromatosis. All of the lesions histologically showed sheets of loosely cohesive polygonal cells with eccentric nuclei and hyaline paranuclear inclusions. Each of the cases showed the following immunophenotype: S-100 (+), synaptophysin(+), vimentin (+), alpha smooth muscle actin (-), CD-30 (-), HMB-45 (-), and pankeratin(-). Ultrastructure of two of the cases yielded similar results showing paranuclear filamentous aggregates of intermediate filaments, cell membrane dense plaques, and rudimentary cell junctions consistent with nerve sheath differentiation. Tonofilaments, dense bodies, microtubules, neurosecretory granules, and melanosomes were not identified. Each of the patients died of widely metastatic disease within 1 year of diagnosis.
CONCLUSIONS: Cutaneous epithelioid malignant nerve sheath tumor is a potentially aggressive tumor capable of showing rhabdoid differentiation thus simulating a variety of neoplasms. Immunophenotyping and ultrastructural analysis reliably discriminates these lesions from melanoma, de-differentiated carcinoma, lymphoma, and rhabdomyosarcoma.

Entities:  

Mesh:

Year:  2000        PMID: 11100813     DOI: 10.1034/j.1600-0560.2000.027010529.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  7 in total

1.  Squamous cell carcinoma with rhabdoid phenotype and osteoclast-like giant cells in a renal-pancreas transplant recipient.

Authors:  K Aljerian; K O Alsaad; R Chetty; D Ghazarian
Journal:  J Clin Pathol       Date:  2006-12       Impact factor: 3.411

2.  Cutaneous malignant rhabdoid tumor in the palm of an adult.

Authors:  Masaki Fujioka; Kenji Hayashida; Chikako Murakami; Masanori Hisaoka; Yoshinao Oda; Masahiro Ito
Journal:  Rare Tumors       Date:  2013-07-12

3.  Semantic interpretation of robust imaging features for Fuhrman grading of renal carcinoma.

Authors:  Andrew Champion; Guolan Lu; Marcus Walker; Sonal Kothari; Adeboye O Osunkoya; May D Wang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2014

4.  PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma.

Authors:  Valerie Glutsch; Marion Wobser; Bastian Schilling; Anja Gesierich; Matthias Goebeler; Hermann Kneitz
Journal:  Dermatopathology (Basel)       Date:  2022-05-02

5.  Surgery and actinomycin improve survival in malignant rhabdoid tumor.

Authors:  Ryan Horazdovsky; J Carlos Manivel; Edward Y Cheng
Journal:  Sarcoma       Date:  2013-02-03

6.  Subcutaneous soft tissue sarcoma with rhabdoid features in a dog.

Authors:  Ayako Sayama; Keiko Okado; Masako Imaoka; Yusuke Yokouchi; Toshimasa Jindo; Wataru Takasaki
Journal:  J Toxicol Pathol       Date:  2014-02-05       Impact factor: 1.628

7.  Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.

Authors:  Jeremie Vitte; Fuying Gao; Giovanni Coppola; Alexander R Judkins; Marco Giovannini
Journal:  Nat Commun       Date:  2017-08-21       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.